Pfizer Inc gets regulatory nod to treat leukemia

By Admin
Worlds largest drugmaker Pfizer Inc has secured regulatory approval to treat one of the four most common types of leukemia, the news reports said. The...

World’s largest drugmaker Pfizer Inc has secured regulatory approval to treat one of the four most common types of leukemia, the news reports said.

The Food and Drug Administration also approved the drug known as Bosulif for adults with the previously treated chronic myeloid leukemia who also have an abnormality known as Philadelphia chromosome, the New-York-based company said.

According to the American Cancer Society in Atlanta, there are expected to be about 5,400 new cases and 601 deaths from blood cancer this year.

The drug Bosulif will compete with Novartis AG’s Tasigna and Bristol-Myers Squibb Co’s Sprycel.

According to the average estimate of six analysts, Pfizer’s treatment is expected to generate $71 million in sales in 2015.

Jorge Cortes, a professor of medicine at the University of Texas MD Anderson Cancer Center, and a lead investigator of the Pfizer-sponsored study on the drug said, “Bosulif is an important new addition to the CML treatment landscape.”

This is Pfizer’s third oncology drug approved in the past 13 months, preceded by Xalkori for lung cancer and Inlyta for the advanced kidney cancer.

Chronic myeloid leukemia produces an excess of white blood cells and is one of the four main types of leukemia that accounts for 15% of all leukemia worldwide.

Pfizer is an American multinational pharmaceutical company based in New York and has its research headquarters in Groton, Connecticut in U.S. It is also the world’s largest pharmaceutical company by revenues.

Share
Share

Featured Articles

WHO Tightens air Quality Guidelines as Pollution Kills 7mn

World Health Organisation tightens air pollution guidelines to safeguard health; COVID prompts WHO to redefine 'air-borne' as it relates to diseases

WHO Health Chatbot Built on 'Humanised' GenAI

World Health Organisation's GenAI digital health tool is built using ‘AI humanisation’ tech & designed to ease burden on health workers & educate on health

Costco Weight-Loss Drugs Move Highlights US AOM Growth

Costco move to partner with online healthcare provider Sesame to provide members with weight-loss drugs including Wegovy signals US anti-obesity boom

AstraZeneca Company Profile, as CEO Soriot Lands pay Deal

Medical Devices & Pharma

US Academic Medical Centres 'Struggling' says McKinsey

Hospitals

J&J Community Initiatives Tackle US Healthcare Chasm

Medical Devices & Pharma